We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » After Consult With FDA on Serada, Depomed Plans Phase III Trial
After Consult With FDA on Serada, Depomed Plans Phase III Trial
January 22, 2010
Depomed plans to file a special protocol assessment (SPA) for a second Phase III trial of Serada by February, after the FDA asked for a redesigned study to demonstrate efficacy in treating menopausal hot flashes.